In the Neurology study of up to 8,818 REGARDS participants, genetic predisposition to higher pulse pressure—not APOE alone—was linked to dementia-related death, with each increase in pulse pressure polygenic risk associated with a 16% higher mortality risk (HR 1.16). The signal emerged in a large U.S. cohort enriched for Black adults, where APOE-related effects appeared attenuated among people with African ancestry at the APOE locus.

Why It Matters To Your Practice

• Genetic risk tied to vascular traits may help explain why some patients with HTN-related physiology face higher downstream dementia risk.

• The finding reinforces that cardiovascular and dementia pathways may overlap, especially around pulse pressure as a marker of arterial stiffness and vascular aging.

• The study adds needed data from a diverse cohort, helping clinicians avoid overreliance on genetic findings derived mainly from White populations.

Clinical Benefits

• Supports aggressive management of modifiable vascular risk factors, including blood pressure control, in patients concerned about long-term cognitive health.

• Offers a clearer counseling point: vascular health may matter not just for stroke and heart disease, but also for dementia progression and dementia-related mortality.

• May help frame pulse pressure as a clinically relevant signal when assessing older adults with elevated systolic pressure and widening pulse pressure.

Managing Risks

• Do not use this study alone to guide genetic testing or dementia prediction; the association was with dementia-related death, not clearly with incident cognitive impairment.

• APOE remains important, but its effect may vary by ancestry, underscoring the need for caution when interpreting genetic risk across diverse patients.

• The authors noted possible undercapture of dementia as a cause of death in U.S. records, so risk estimates may be incomplete.

The Bottom Line

• For NPs and PAs, the practical takeaway is simple: vascular risk and brain risk are closely linked, and genes associated with higher pulse pressure may identify patients at greater risk of dementia-related death.

• Until genetics become more actionable, prioritize evidence-based HTN and cardiometabolic risk reduction while watching for cognitive decline in high-risk adults.